Secondary Erythema Nodosum Persisting After NSAIDs and Compression: Next-Line Management

Clinical Scenario

Secondary erythema nodosum presenting with tender erythematous nodules on the lower extremities that have not resolved with standard first-line measures. This protocol defines the structured next step when initial management proves insufficient.

First-Line Treatment — Inadequate Response

Initial management with compression bandages and limb elevation for edema and pain relief, combined with indomethacin or naproxen for pain control, did not achieve the expected outcome: resolution of tender erythematous nodules on the lower extremities within 1–6 weeks. This failure to reach the treatment target is the trigger for escalation.

Next-Line Approach (Partial Overview)

For refractory secondary erythema nodosum, the protocol centres on an oral iodide preparation given in a structured, tapered schedule.

The complete dosing regimen, tapering steps, and monitoring details are available in the full protocol below.

Treatment Goal

Resolution of tender erythematous nodules on the lower extremities.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1007/s40257-021-00592-w

In refractory disease, oral potassium iodide may be used with a dose of 300–900 mg daily divided into three doses and tapered to 150 mg/day.

View source ↗